THC Farmaceuticals Inc
OTC:CBDG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0073
0.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
THC Farmaceuticals Inc
THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The firm through its subsidiary CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The firm is engaged cannabis formulations, edibles, and delivery systems of cannabis. The company manufactures and markets cannabis extract products made from cannabis. The firm's facility is located in Southern California. The company provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The firm is focusing on the research of psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.
THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The firm through its subsidiary CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The firm is engaged cannabis formulations, edibles, and delivery systems of cannabis. The company manufactures and markets cannabis extract products made from cannabis. The firm's facility is located in Southern California. The company provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The firm is focusing on the research of psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.
